Carregant...
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
Mevalonate kinase deficiency (MKD) is a severe autoinflammatory disease caused by recessive mutations in MVK resulting in reduced function of the enzyme mevalonate kinase, involved in the cholesterol/isoprenoid pathway. MKD presents with periodic episodes of severe systemic inflammation, poor qualit...
Guardat en:
Autors principals: | , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Hindawi Limited
2018-01-01
|
Col·lecció: | Case Reports in Pediatrics |
Accés en línia: | http://dx.doi.org/10.1155/2018/3514645 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|